Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Neoadjuvant Chemoradiotherapy in Rectal Cancer: Are there New Drug Combinations on the Horizon? (CROSBI ID 790021)

Druge vrste radova | ostalo

Reinhold Arnold Cristoph, Mangesius Julian, Jäger Robert, Ganswindt Ute Neoadjuvant Chemoradiotherapy in Rectal Cancer: Are there New Drug Combinations on the Horizon? // MEMO. 2020.

Podaci o odgovornosti

Reinhold Arnold Cristoph, Mangesius Julian, Jäger Robert, Ganswindt Ute

engleski

Neoadjuvant Chemoradiotherapy in Rectal Cancer: Are there New Drug Combinations on the Horizon?

SummaryNeoadjuvant chemoradiotherapy is a well-established standard treatment for locally advancedrectal cancer and has led to a remarkable improve-ment in local control. However, distant recurrencesstill pose a notable threat and local failure, albeit in-creasingly rare, can lead to unfavorable clinical situ-ations. In this short review, we discuss three promis-ing new strategies to improve rectal cancer treatment:total neoadjuvant therapy, short course radiotherapy, and immune checkpoint inhibitors.

rectal cancer, neoadjuvant treatment

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

MEMO

2020.

nije evidentirano

objavljeno

Povezanost rada

Kliničke medicinske znanosti